The White House has reversed a decision to cut $2 billion in federal grants for mental health and addiction services, which had threatened numerous programs across the country. This move comes amid widespread concern over the ongoing drug crisis and the need for continued support for vulnerable populations.

## White House Reverses $2 Billion Cut to Mental Health Grants

In a significant policy reversal, the White House has decided to restore $2 billion in federal grants that support mental health and addiction services, which had been previously cut by the Trump administration.

This decision comes as public health experts and advocates express deep concern over the ongoing drug crisis in the United States, which has been exacerbated by funding reductions to essential services.

The cuts, which were announced late Tuesday, had targeted over 2,000 discretionary grants distributed by the Substance Abuse and Mental Health Services Administration (SAMHSA).

These grants are crucial for programs addressing addiction treatment, mental health care, homelessness, and suicide prevention.

The abrupt cancellation of funding had left many organizations scrambling to find alternative sources of support, with some facing immediate layoffs and service disruptions.

Ryan Hampton, founder of the nonprofit Mobilize Recovery, highlighted the dire consequences of the cuts, stating that the loss of funding would leave communities defenseless against the ongoing overdose crisis.

He emphasized that the cuts would dismantle the recovery infrastructure built over years, potentially leading to preventable deaths.

The decision to reverse the cuts has been met with relief from various stakeholders, including politicians and nonprofit leaders who had been vocal in their opposition to the funding reductions.

Connecticut Governor Ned Lamont criticized the initial cuts as a threat to essential services, stating that they jeopardized care for vulnerable residents.

Similarly, US Senator Patty Murray expressed that the administration's claims of addressing the opioid crisis were undermined by the cuts, calling for bipartisan support to ensure the restoration of funding.

The funding restoration is seen as a critical step in addressing the mental health and addiction crises that have plagued the nation.

Public health advocates argue that sustained investment in these services is essential for preventing further loss of life and supporting individuals in recovery.

As the nation grapples with the ongoing challenges posed by addiction and mental health issues, the reversal of these cuts may provide a much-needed lifeline for organizations dedicated to helping those in need.

The decision underscores the importance of federal support in combating the drug epidemic and ensuring access to vital health services.

In conclusion, the White House's decision to reverse the $2 billion cuts to mental health and addiction grants reflects a recognition of the critical role these services play in addressing the ongoing crises.

As communities begin to recover from the impacts of these cuts, the focus will now shift to ensuring that funding remains stable and that programs can continue to provide essential support to those affected by addiction and mental health challenges.

White House Reverses $2 Billion Cut to Mental Health Grants

white-house-reverses-2-billion-cut-to-mental-health-grants

NVIDIA and Natera have announced a collaboration to enhance AI foundation models for precision medicine. This partnership aims to leverage Natera's extensive datasets and NVIDIA's computing power to improve diagnostics and personalized therapies.

## NVIDIA and Natera Collaborate on AI for Precision Medicine

NVIDIA and Natera, a leader in cell-free DNA testing and precision medicine, have announced a significant collaboration aimed at advancing AI foundation models for precision medicine.

This partnership is designed to enhance the development of Natera's multimodal AI foundation model platform, which will expand applications across the field of precision medicine.

Under this collaboration, Natera will integrate its unique longitudinal and multi-time point in vivo datasets with NVIDIA's high-performance computing platforms and AI frameworks.

The goal is to establish the computational infrastructure necessary to train and deploy large-scale AI models on complex medical datasets, which will enable more precise diagnostics and deeper biological insights.

Natera's AI solutions are anchored by one of the largest multimodal, longitudinal oncology datasets globally.

This extensive dataset is crucial for addressing complex challenges in oncology, including the prediction of immunotherapy responses and neoantigen identification.

For instance, Natera's NeoSelect™ algorithm has outperformed 25 established neoantigen prediction algorithms, while its NeoPredict™ algorithm has shown more than a two-fold improvement in predicting immunotherapy responses compared to the current clinical standard, tumor mutational burden.

The collaboration is expected to significantly enhance the capabilities of Natera's AI models, which are already proving useful for discovering new drug targets, predicting therapy responses, and identifying new prognostic biomarkers.

Since the announcement of this platform, Natera has experienced substantial engagement from pharmaceutical partners, leading to new data collaborations and growth in its data business.

Matthew Rabinowitz, co-founder and executive chairman of Natera, emphasized the vision behind this partnership, stating, "By combining Natera's extensive AI-ready longitudinal data and machine learning with NVIDIA's compute and software stacks, we can train at unprecedented scale." This collaboration marks a meaningful step forward in personalized diagnostics and therapeutic insights, enabling AI systems that can interpret biology across different data types.

Natera plans to utilize several NVIDIA platforms, including NVIDIA Parabricks for accelerating bioinformatics workflows, NVIDIA BioNeMo for optimizing large-scale model training, and the NVIDIA NeMo Agent Toolkit for building multi-agent AI systems tailored for clinical and research applications.

Early engineering milestones have already demonstrated significant improvements, such as a 75.7% reduction in running time and a 59.2% decrease in costs for genomic analysis using Parabricks.

Rory Kelleher, senior director at NVIDIA, noted that "AI is advancing every aspect of precision medicine, enhancing the speed and accuracy of biological discovery for better outcomes." He highlighted that the combination of NVIDIA's advanced AI frameworks and Natera's unique data is unlocking better diagnostics and personalized treatments.

Natera's global testing and research networks generate vast amounts of data each year, providing the necessary scale to train increasingly sophisticated multimodal AI models.

Together with NVIDIA's computing platforms, the companies aim to develop AI systems that deliver more accurate, data-driven insights across precision oncology and organ health.

This collaboration not only underscores Natera's commitment to integrating cutting-edge technology into healthcare but also positions the company for continued growth in the precision medicine market.

As the partnership progresses, it is expected to drive advancements in AI model development and application, ultimately leading to improved healthcare outcomes.

In summary, the collaboration between NVIDIA and Natera represents a significant milestone in the integration of AI technology into precision medicine, with the potential to transform diagnostics and therapeutic strategies in oncology and beyond.

NVIDIA and Natera Collaborate on AI for Precision Medicine

nvidia-and-natera-collaborate-on-ai-for-precision-medicine

The COVID-19 pandemic has significantly affected mental health globally, with a notable increase in anxiety and depression. As recovery efforts continue, the long-term effects of the virus, including long COVID, are becoming more apparent, necessitating ongoing support and resources for mental health care.

## The Ongoing Mental Health Impact of COVID-19

The COVID-19 pandemic has had profound effects on mental health worldwide, with a reported increase in anxiety and depression by 25% during the first year of the pandemic, according to the World Health Organization (WHO).

This surge in mental health issues has been attributed to various stressors, including social isolation, fear of infection, and financial uncertainties, which have disproportionately affected young people and women.

As we navigate the aftermath of the pandemic, the concept of long COVID has emerged as a significant concern.

Long COVID refers to a range of symptoms that persist for weeks or months after the initial COVID-19 infection, affecting approximately 5% to 10% of those infected, regardless of the severity of their initial illness.

Symptoms can include fatigue, difficulty concentrating, and psychological issues such as anxiety and depression, which can severely impact daily life and overall well-being.

The mental health implications of long COVID are particularly alarming.

A study analyzing data from over 236,000 COVID-19 patients found that 34% were diagnosed with a neurological or psychiatric disorder within six months of infection, with anxiety disorders being the most common at 17%.

This highlights the urgent need for healthcare systems to prepare for the long-term mental health needs of COVID-19 survivors.

In response to these challenges, various governments and organizations have begun to implement strategies aimed at addressing the mental health crisis exacerbated by the pandemic.

For instance, the Scottish Government has outlined a plan to support mental health recovery, emphasizing the importance of personalized care and the need to adapt approaches as new mental health needs arise.

This plan aims to ensure that individuals receive the right support at the right time, recognizing that recovery is not a linear process.

Despite these efforts, significant gaps in mental health services remain.

The pandemic has disrupted many essential health services, leaving many individuals without the care they need.

The WHO has reported that mental health services were among the most disrupted during the pandemic, with many countries struggling to provide adequate support for those experiencing mental health issues.

Moreover, the stigma surrounding mental health has been challenged during this time, with more people openly discussing their struggles and seeking help.

This cultural shift presents an opportunity to further destigmatize mental health issues and promote a supportive environment for those in need.

As we look to the future, it is clear that the mental health impacts of COVID-19 will be felt for years to come.

The need for increased investment in mental health resources is critical, as many countries currently allocate only a small percentage of their health budgets to mental health services.

The WHO has called for a global step-up in investment to ensure that mental health support is accessible to all, particularly in light of the chronic underfunding that has historically plagued mental health services.

In conclusion, while there is a growing recognition of the mental health challenges posed by the COVID-19 pandemic, the journey to recovery is ongoing.

Continued efforts to provide support, address stigma, and invest in mental health resources will be essential in helping individuals and communities heal from the psychological impacts of this unprecedented global crisis.

The long-term effects of both the virus and the pandemic's social consequences will require sustained attention and action from health systems worldwide.

The Ongoing Mental Health Impact of COVID-19

the-ongoing-mental-health-impact-of-covid-19

As OpenAI's ChatGPT Health gains traction in the medical field, some doctors express concerns about its potential to harm patients. Issues such as inaccuracies, data privacy, and the risk of over-reliance on AI tools are at the forefront of discussions among healthcare professionals.

## Concerns Rise Over OpenAI's ChatGPT Health and Patient Safety

The introduction of OpenAI's ChatGPT Health has sparked a mix of enthusiasm and apprehension among healthcare professionals.

While some doctors see the potential for AI to enhance patient care, others worry that reliance on such technology could lead to significant risks, including misdiagnoses and compromised patient safety.

Robert Pearl, a former CEO of Kaiser Permanente and a professor at Stanford medical school, believes that generative AI tools like ChatGPT could become essential in medical practice.

He argues that no physician practicing high-quality medicine will be able to do so without utilizing AI tools in the near future.

However, this optimism is tempered by concerns about the accuracy and reliability of AI-generated information.

Many physicians have reported mixed experiences with ChatGPT.

For instance, Monalisa Tailor, an internal medicine physician, noted that early interactions with the chatbot revealed inaccuracies in clinical guidance, leading her practice to discontinue its use.

In contrast, orthopedic spine surgeon Daniel Choi found the tool helpful for administrative tasks, such as drafting job listings, which he completed in a fraction of the time it would typically take.

This dichotomy highlights the varying levels of trust and acceptance among medical professionals regarding AI tools.

A recent poll by the Medical Group Management Association indicated that only about 10% of medical group leaders regularly use AI tools in their practices, with many expressing a desire for more evidence of their effectiveness.

Concerns about the integration of AI with electronic health record systems and the potential for inaccuracies in patient care are significant barriers to adoption.

Patients themselves are also wary of AI's role in their healthcare.

A Pew Research Center poll found that approximately 60% of US adults would feel uncomfortable if their healthcare provider relied on AI for diagnosing diseases or recommending treatments.

This sentiment underscores the need for healthcare providers to approach AI integration cautiously, particularly in clinical settings.

Legal experts and medical organizations are calling for regulatory measures to ensure the safe use of AI in healthcare.

Mason Marks, a health law professor, emphasized the importance of evaluating the accuracy and safety of AI tools before they are integrated into medical practice.

The American Medical Association has also advocated for greater government oversight of AI technologies to protect patients from potential harm.

Despite the challenges, proponents of AI in healthcare argue that it has the potential to revolutionize the field.

Adam Rodman, an assistant professor at Harvard Medical School, noted that AI could significantly reduce administrative burdens and improve the efficiency of medical practice.

However, he cautioned that the technology must be used thoughtfully to avoid undermining the critical thinking skills that are essential for effective medical practice.

The potential for AI to "hallucinate" or generate false information is another significant concern.

Experts warn that inaccuracies in AI-generated data could lead to serious medical errors, particularly if healthcare providers rely on these tools without verifying the information.

As the healthcare industry navigates the integration of AI technologies like ChatGPT, it is crucial for physicians to remain vigilant.

They are advised to use AI tools cautiously, ensuring that they do not replace professional judgment or compromise patient confidentiality.

In conclusion, while OpenAI's ChatGPT Health presents exciting possibilities for enhancing medical practice, the concerns surrounding its use cannot be overlooked.

Ongoing discussions about regulation, accuracy, and the ethical implications of AI in healthcare will be essential as the industry moves forward in this new technological landscape.

The balance between leveraging AI's capabilities and safeguarding patient care will be a defining challenge for the future of medicine.

Concerns Rise Over OpenAI's ChatGPT Health and Patient Safety

concerns-rise-over-openai-s-chatgpt-health-and-patient-safety

Robert F. Kennedy Jr's recent directives as Secretary of Health and Human Services focus on reforming dietary standards and vaccine policies. His controversial stance on public health issues raises questions about the future of health regulations and the potential impact on chronic disease management in the US.

## RFK Jr.'s Health Directives: Implications for Public Health Policy

Kennedy Jr (RFK Jr) has taken a bold stance as the newly confirmed Secretary of the Department of Health and Human Services (HHS), aiming to reshape America's public health landscape.

His directives focus on dietary reforms and vaccine policies, which could significantly impact public health initiatives across the nation.

Kennedy's approach to public health is rooted in his commitment to combat chronic diseases, which he claims have reached epidemic levels in the US He has emphasized the need to address the consumption of ultra-processed foods, food additives, and environmental toxins that he believes contribute to health issues like diabetes and autism.

His slogan, "Make America Healthy Again," encapsulates his vision for a healthier nation, prioritizing wholesome food and clean water.

One of Kennedy's primary targets is the food industry, particularly the prevalence of ultra-processed foods that he argues are detrimental to children's health.

He has called for stricter regulations on food additives and dyes, which he claims are linked to various health problems.

However, experts caution that implementing such sweeping changes will face significant political and bureaucratic challenges, especially given the entrenched interests of the food industry.

In addition to dietary reforms, Kennedy's tenure is marked by his controversial views on vaccines.

He has long been a skeptic of vaccine safety, linking them to autism—a claim that has been widely discredited by scientific research.

His appointment has raised concerns among public health experts about the potential erosion of vaccine coverage and the risk of preventable diseases.

Critics argue that his influence could undermine trust in established health recommendations, particularly as he oversees key agencies like the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA).

Kennedy's proposed changes extend beyond food and vaccines.

He has indicated a desire to overhaul the FDA, criticizing its current operations and calling for a reduction in staffing and funding.

This aligns with the Trump administration's broader agenda of downsizing federal agencies, which Kennedy believes has led to inefficiencies in public health policy.

His plans include redirecting funds from traditional research towards alternative health approaches, which could significantly alter the landscape of health research in the US.

The restructuring of HHS under Kennedy's leadership is also expected to streamline operations by consolidating various divisions and focusing on core health priorities.

This includes the creation of the Administration for a Healthy America (AHA), which aims to enhance coordination of health resources, particularly for low-income populations.

However, the effectiveness of these changes remains to be seen, as they will require navigating complex regulatory frameworks and industry pushback.

Kennedy's controversial views and proposed reforms have sparked a heated debate about the future of public health in America.

While some support his focus on chronic disease and dietary reform, others express concern that his skepticism towards established medical practices could lead to detrimental outcomes for public health.

As he embarks on this ambitious agenda, the implications of his directives will likely unfold in the coming months, shaping the trajectory of US health policy for years to come.

In conclusion, RFK Jr's tenure as HHS Secretary represents a significant shift in the approach to public health in the United States.

His focus on dietary reform and vaccine skepticism poses both opportunities and challenges, raising critical questions about the balance between public health priorities and industry interests.

The effectiveness of his initiatives will depend on his ability to navigate the complex landscape of health policy and garner support from both lawmakers and the public.

RFK Jr.'s Health Directives: Implications for Public Health Policy

rfk-jr-s-health-directives-implications-for-public-health-policy

ChatGPT Health, a new AI tool for health and wellness, offers significant benefits such as improved patient engagement and support for healthcare professionals. However, it also presents challenges, including privacy concerns and limitations in clinical accuracy. Experts emphasize the need for careful integration of AI in healthcare to maximize its potential while addressing its drawbacks.

## Evaluating ChatGPT Health: Pros and Cons in Medicine

OpenAI's recent introduction of ChatGPT Health aims to enhance health and wellness support for the millions who seek medical information daily.

This innovative tool has sparked discussions among experts regarding its potential benefits and drawbacks in the healthcare sector.

One of the primary advantages of ChatGPT Health is its ability to assist patients in understanding their medical data.

Dr David Liebovitz, an AI-in-medicine expert at Northwestern University, notes that the platform can help patients interpret lab results and prepare questions for healthcare appointments.

This capability represents a significant improvement over traditional methods, where patients often rely on internet searches for health information.

Moreover, ChatGPT Health can streamline clinical workflows by automating tasks such as generating discharge summaries and supporting triage processes.

This efficiency allows healthcare professionals to focus more on patient care rather than administrative burdens, potentially improving overall healthcare delivery.

In medical education, ChatGPT has shown promise by achieving notable performance on standardized tests, indicating its potential as a learning tool for both students and professionals.

Its ability to provide instant access to vast medical knowledge can enhance training efficiency and address resource limitations in medical education.

Despite its advantages, ChatGPT Health is not without limitations.

A significant concern is the lack of privacy protections for health data shared with the platform.

Unlike conversations with healthcare providers, data shared with ChatGPT is not protected by HIPAA, raising potential legal and ethical issues.

This is particularly concerning for sensitive health matters, such as mental health or reproductive health, where confidentiality is paramount.

Additionally, while ChatGPT can process and synthesize vast amounts of information, it lacks clinical experience and emotional intelligence, which are crucial in healthcare settings.

The model's inability to process visual data further limits its effectiveness in certain medical contexts, such as radiology.

Research has also highlighted the potential for biases in AI therapy chatbots, which could lead to harmful consequences for users.

For instance, studies have shown that AI models may exhibit stigma towards certain mental health conditions, which could discourage individuals from seeking necessary care.

Looking ahead, the integration of AI tools like ChatGPT Health into healthcare systems requires careful consideration of both their benefits and limitations.

Experts emphasize the importance of establishing appropriate guardrails to ensure safe and effective use.

One promising approach is the development of on-device AI models that run locally on patients' devices, thereby eliminating privacy concerns associated with cloud-based systems.

This could empower patients to manage their health data more securely while still benefiting from AI assistance.

As AI technology continues to evolve, it is crucial for healthcare professionals to remain engaged in discussions about its ethical implications and practical applications.

The collaboration between AI and human expertise is essential to enhance patient care while safeguarding against potential risks.

In conclusion, while ChatGPT Health presents exciting opportunities for improving healthcare delivery and patient engagement, it also poses significant challenges that must be addressed.

A balanced approach that leverages the strengths of AI while mitigating its weaknesses will be key to its successful integration into the medical field.

Evaluating ChatGPT Health: Pros and Cons in Medicine

evaluating-chatgpt-health-pros-and-cons-in-medicine

OpenAI and Anthropic are positioning themselves to leverage AI in the health care sector, aiming to integrate health data into existing platforms rather than creating new applications. This strategy capitalizes on their established user bases and the evolving health care infrastructure.

## OpenAI and Anthropic Target Health Care for AI Expansion

OpenAI and Anthropic are increasingly eyeing the health care sector as a significant market for artificial intelligence (AI) applications.

Both companies are not looking to develop new health-focused apps but rather to integrate health data into their existing platforms, such as ChatGPT and Claude, respectively.

The strategic advantage for these tech giants lies in their already established user bases.

OpenAI's ChatGPT and Anthropic's Claude have millions of daily active users, making it easier to distribute health-related features without the need for a separate application.

This approach allows them to embed health data into tools that users are already familiar with, thereby enhancing user engagement and utility.

The recent pledge by the Centers for Medicare & Medicaid Services (CMS) emphasizes the need for conversational AI assistants that can securely access health information with patient consent.

This aligns with OpenAI and Anthropic's capabilities, as they can leverage their existing technologies to meet these requirements.

The integration of health data into their platforms could facilitate personalized health support, guiding users to appropriate care when necessary.

Historically, consumer technology companies have struggled to penetrate the health care market due to the complexities involved in accessing and managing health data.

However, advancements in health care infrastructure, particularly through initiatives like the CMS pledge, are making it easier for companies to connect with health data sources.

If these infrastructures become more ubiquitous, the challenge will shift from accessing health data to effectively utilizing it within consumer applications.

The potential for AI in health care is vast.

According to McKinsey, the long-term opportunity for AI in corporate use cases, including health care, is estimated at $4.4 trillion in added productivity growth.

This figure underscores the transformative potential of AI technologies in improving health outcomes and operational efficiencies within the sector.

Moreover, the demand for AI applications in health care is growing rapidly.

In 2025, the market for AI applications is projected to reach $19 billion, with a significant portion allocated to verticals like health care.

This growth reflects a broader trend where enterprises are prioritizing immediate productivity gains through AI, rather than long-term infrastructure investments.

As AI technologies continue to evolve, the capabilities of large language models (LLMs) are also advancing.

Recent developments have shown that these models can now perform complex reasoning and decision-making tasks, which are crucial for applications in health care.

For instance, OpenAI's models have demonstrated the ability to pass medical licensing examinations, indicating their potential to assist in clinical decision-making.

The integration of AI into health care is not without challenges.

Companies must navigate regulatory landscapes and ensure that their technologies comply with health care standards.

Additionally, there is a need for robust data privacy measures to protect patient information as these technologies are deployed.

In conclusion, OpenAI and Anthropic are strategically positioning themselves to capitalize on the health care market by embedding AI capabilities into their existing platforms.

This approach not only leverages their established user bases but also aligns with the evolving health care infrastructure that is becoming more conducive to AI integration.

As the demand for AI in health care continues to grow, these companies are well-placed to lead the charge in transforming how health care is delivered and experienced.

OpenAI and Anthropic Target Health Care for AI Expansion

openai-and-anthropic-target-health-care-for-ai-expansion

OpenAI has introduced ChatGPT Health, a feature designed to analyze users' medical records and wellness data to provide personalized health insights. While the tool aims to enhance user understanding of health-related questions, privacy advocates express concerns over data security and the potential misuse of sensitive information.

## OpenAI Launches ChatGPT Health for Medical Record Analysis

OpenAI has launched ChatGPT Health, a new feature that allows users in the US to integrate their personal health information with the AI to better manage health-related inquiries.

This initiative aims to provide users with personalized responses based on their medical records and data from wellness apps like MyFitnessPal and Apple Health.

The feature operates as a separate space within the ChatGPT platform, ensuring enhanced privacy and security for sensitive health information.

Conversations in ChatGPT Health are encrypted and isolated from other chats, meaning that this data will not be used to train OpenAI's AI models.

OpenAI emphasizes that the tool is designed to support, not replace, medical care, and is not intended for diagnosis or treatment.

Users can connect their medical records through a partnership with b.well, which facilitates integration with approximately 2.2 million healthcare providers.

This allows ChatGPT Health to analyze lab results, visit summaries, and clinical histories, providing users with tailored advice on health management.

The feature is currently available only in the US, and users must sign up for a waitlist to gain access as it is being rolled out gradually.

OpenAI's decision to launch ChatGPT Health comes in response to the growing demand for health-related inquiries, with over 230 million people globally asking health and wellness questions each week.

The company has worked with more than 260 physicians over the past two years to refine the product, ensuring that it meets safety and clarity standards.

Despite the potential benefits, privacy advocates have raised concerns about the handling of sensitive health data.

Andrew Crawford from the Center for Democracy and Technology highlighted the importance of maintaining strict safeguards around users' health information, especially as AI companies explore new business models.

He noted that while AI tools can empower patients, the sensitivity of health data necessitates robust protection measures.

Topic

Medicine

Recent articles:

NVIDIA and Natera Collaborate on AI for Precision Medicine

The Ongoing Mental Health Impact of COVID-19

Concerns Rise Over OpenAI's ChatGPT Health and Patient Safety

RFK Jr.'s Health Directives: Implications for Public Health Policy

Evaluating ChatGPT Health: Pros and Cons in Medicine

OpenAI and Anthropic Target Health Care for AI Expansion

OpenAI Launches ChatGPT Health for Medical Record Analysis

OpenAI Launches ChatGPT Health for Personalized Medical Insights

Flu Activity in the U.S. Expected to Rise for Weeks, CDC Warns

New York's Children's Mental Health Services Overhauled After Lawsuit

Vermont Health Officials Reject CDC Vaccine Recommendations

40 Million Users Turn to ChatGPT Daily for Health Questions

CDC Updates Childhood Immunization Schedule Following Review

Trump Administration Reduces Recommended Childhood Vaccines

HHS Overhauls US Childhood Vaccine Schedule, Reducing Recommendations

Trump Regrets Heart Health CT Scan Amid Aspirin Controversy

Minnesota Experts Alarmed by New CDC Vaccine Recommendations

Flu-like Illness Activity Reaches Record Highs in the U.S.

Public Health Leaders Respond to Changes in Childhood Vaccine Schedule